...
首页> 外文期刊>Stem cell research >Generation of gene-corrected iPSC line from Parkinson's disease patient iPSC line with alpha-SNCA A53T mutation - ScienceDirect
【24h】

Generation of gene-corrected iPSC line from Parkinson's disease patient iPSC line with alpha-SNCA A53T mutation - ScienceDirect

机译:从帕金森氏病患者的iPSC系中产生具有α-SNCAA53T突变的基因校正的iPSC系-ScienceDirect

获取原文
           

摘要

Parkinson's disease (PD) is the second most common age-related neurodegenerative disorder. PD can result from a mutation of alpha-synuclein (α-SNCA), such as α-SNCA A53T. Using episomal vectors, induced pluripotent stem cells (iPSCs) were generated from skin fibroblasts with the α-SNCA A53T mutation. A huge bacterial artificial chromosome (BAC) harboring the normal α-SNCA gene successfully corrected the α-SNCA A53T-mutant iPSCs. Melting curve analysis for allelic composition indicated that the BAC DNA was precisely targeted to the α-SNCA A53T mutation allele, without random integration. The corrected PD-iPSCs displayed the normal karyotype and pluripotency, with the capability to differentiate to any cell type.
机译:帕金森氏病(PD)是第二大最常见的年龄相关性神经退行性疾病。 PD可能是由α-突触核蛋白(α-SNCA)突变(例如α-SNCAA53T)引起的。使用附加型载体,从具有α-SNCAA53T突变的皮肤成纤维细胞中产生诱导性多能干细胞(iPSC)。带有正常α-SNCA基因的巨大细菌人工染色体(BAC)成功地纠正了α-SNCAA53T突变iPSC。等位基因组成的熔解曲线分析表明,BAC DNA精确地靶向α-SNCAA53T突变等位基因,没有随机整合。校正后的PD-iPSC显示出正常的核型和多能性,能够分化为任何细胞类型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号